Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib significantly improved skin and hair conditions without side effects.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Lithium temporarily stops cell division in plant cells, but this can be reversed with certain chemicals.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Both fluoxetine and clomipramine effectively treat dog lick dermatitis, but fluoxetine works faster with lower recurrence, while clomipramine has fewer side effects.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

The metoprolol-spironolactone combination improves heart function in patients with coronary heart disease and heart failure.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Pranlukast and mirabegron may work as new diabetes drugs.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tigason improved hair growth in a boy with monilethrix without side effects.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.